"Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. About a fifth of the 46 guidelines writers acknowledged previously taking money from Eli Lilly for speaking, consulting or research."
Below the New York Times provides a summary of Crawford's selective disclosure and concealment of his financial holdings while he was
Commissioner, noting Crawford's ignoble tenure:
FDA's Dr. Steven Galson, like his predecessor who now occupies a position in the Commissioner's office, demonstrates disconnectedness from reality, much like Nero who fiddled while Rome burned…
"UK regulators did not receive findings that might have warned them of damage TGN1412 could do."
"The drugs most commonly used to soothe agitation and aggression in people with Alzheimer’s disease are no more effective than placebos for most patients, and put them at risk of serious side effects, including confusion, sleepiness and Parkinson’s disease-like symptoms, researchers are reporting
today."
According to a investigative report issued by the Israeli Health Ministry, the doctors "conducted illegal and unethical testing on thousands of elderly patients for years.
A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH
Tomorrow Hearing FDA’s Emergency Research Rule–CNN News at 8:00 P.M will inform the public about how the FDA Rule impacts on American citizens who can be put at increased risk to test an experimental treatment without their knowledge or consent.
Two actions by the FDA last week demonstrate where the agency’s priority lies—and that priority is NOT to protect public safety, NOT to protect children’s safety. FDA’s priority—as demonstrated by its actions—is approval of new drugs or approval for expanded even dubious uses of patented drugs.
The battle lines were drawn between those who recognize the corrosive effect that the pharmaceutical industry is having on the safety and integrity of medicine and medical research, and the powerful stakeholders–the pharmaceutical-academic industrial complex.
Urge your Senators to VOTE YES for the Child Medication Safety Act (S. 4041, HR 1790) !!!
Two especially timely conferences focus on MEDICINE AND THE LAW:
